EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹48 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹66 Cr |
What is the latest Long Term Provisions ratio of EMCURE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹42 Cr |
| Mar2021 | ₹66 Cr |
How is Long Term Provisions of EMCURE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | 9.83 | |
| Mar2024 | ₹43 Cr | 9.21 | |
| Mar2023 | ₹40 Cr | -5.80 | |
| Mar2022 | ₹42 Cr | -36.14 | |
| Mar2021 | ₹66 Cr | - | |
Compare Long Term Provisions of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹26,845.5 Cr | 1.7% | -0.8% | 0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,170.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,038.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,357.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,414.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,015.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 1.7% |
-0.8% |
0.8% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses